Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Enhanced and Accelerated Repopulation of Mutant C-Kit Immunodeficient Mice By Transplants of Primary Chronic and Acute Myeloid Leukemic Human Cells

Naoto Nakamichi, MD PhD, Colin A. Hammond, Paul H. Miller, PhD, Katharina Rothe, PhD, Philip A Beer, BM, MRCP, MRCPath, Xiaoyan Jiang, MD PhD, Michael W. Deininger, MD PhD, Connie J. Eaves, PhD

Blood (2016) 128 (22): 4537.

https://doi.org/10.1182/blood.V128.22.4537.4537

Published: 2016

Journal Articles

Prospective Phase 2 Trial of High-Dose Gemcitabine/Busulfan/Melphalan (Gem/Bu/Mel) with Autologous Stem-Cell Transplant (ASCT) without Post-ASCT Maintenance, in Hodgkins Lymphoma Patients at High Risk of Post-Transplant Recurrence Comparison with a Concurrent Matched Cohort Treated with BEAM

Blood (2015) 126 (23): 1980.

https://doi.org/10.1182/blood.V126.23.1980.1980

Published: 2015

Journal Articles

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

Regine Grosse, MD, Suzan Acar, Bjoern Schoennagel, MD, Roland Fischer, PhD, Jin Yamamura, MD, Gritta Janka, MD PhD, Peter Nielsen, MD

Blood (2015) 126 (23): 3358.

https://doi.org/10.1182/blood.V126.23.3358.3358

Published: 2015

Journal Articles

Longterm Multilineage Human Hematopoietic Repopulation of Untreated KIT-Mutant Immunodeficient Mice

Paul H. Miller, Gabrielle Rabu, David J.H.F. Knapp, Alice M.S. Cheung, PhD, Kiran Dhillon, Philip A. Beer, MRCP, FRCPath, PhD, Connie J. Eaves, PhD

Blood (2014) 124 (21): 2415.

https://doi.org/10.1182/blood.V124.21.2415.2415

Published: 2014

Journal Articles

Extreme Heterogeneity Of Myeloablative Total Body Irradiation (TBI) Techniques Across Europe: A Survey Of Acute Leukemia Working Party Of The EBMT

Sebastian Giebel, MD, Leszek Miszczyk, MD, PhD, Krzysztof Slosarek, PhD, Leila Moukhtari, Fabio Ciceri, MD, Jordi Esteve, MD, PhD, Norbert Claude Gorin, MD, Myriam Labopin, MD, Arnon Nagler, MD, MSc, Christoph Schmid, MD, Mohamad Mohty, MD, PhD

Blood (2013) 122 (21): 4565.

https://doi.org/10.1182/blood.V122.21.4565.4565

Published: 2013

Journal Articles

High-Dose Gemcitabine Combined With Busulfan and Melphalan (Gem/Bu/Mel) With Autologous Stem-Cell Transplant (ASCT) In Refractory and Relapsed Myeloma

Yago Nieto, MD, PhD, Nina Shah, MD, Uday R Popat, MD, Roy B Jones, PhD MD, Qaiser Bashir, MD, Rolland Bassett, MS, Benigno C. Valdez, PhD, Borje S Andersson, MD, PhD, Simrit Parmar, MD, Robert Z. Orlowski, M.D., Ph.D, Jatin J. Shah, M.D., Sheeba K. Thomas, M.D., Michael Wang, M.D., Richard E Champlin, MD, Muzaffar Qazilbash, M.D.

Blood (2013) 122 (21): 3346.

https://doi.org/10.1182/blood.V122.21.3346.3346

Published: 2013

Journal Articles

Vorinostat (SAHA) Combined With High-Dose Gemcitabine/Busulfan/Melphalan (SAHA/Gem/Bu/Mel) With Autologous Stem-Cell Transplant (ASCT) In Patients With Refractory Lymphomas

Blood (2013) 122 (21): 2095.

https://doi.org/10.1182/blood.V122.21.2095.2095

Published: 2013

Journal Articles

Beneficial Effects Of Ionizing Radiation To Enhance Anti-Cancer Effects Of RIG-Like Receptor Stimulus

Hironori Yoshino, Ikuo Kashiwakura, PhD

Blood (2013) 122 (21): 4721.

https://doi.org/10.1182/blood.V122.21.4721.4721

Published: 2013

Journal Articles

Would Be Cyclophosphamide, Thalidomide and Dexamethasone (CTD) a Possible Treatment For Multiple Myeloma Where Is Not Possible New Drugs?

Marcelo Bellesso, MD, Marcela Cavalcante de Andrade Silva, MD, Rodrigo Dolphini Velasques, MD, Helena Visnadi, MD, Roberta Shcolnik, MD, Fernanda Salles Seguro, MD, Debora Levy, Andre Neder Ramires Abdo, MD, Rodrigo Santucci, MD, Juliana Pereira, PhD, Gracia Aparecida Martinez, PhD

Blood (2013) 122 (21): 5385.

https://doi.org/10.1182/blood.V122.21.5385.5385

Published: 2013

Journal Articles

High-Dose Infusional Gemcitabine (Gem) Combined with Busulfan (Bu) and Melphalan (Mel) (GemBuMel) with Autologous Stem-Cell Transplant (ASCT) in Patients with Refractory Lymphoid Malignancies

Blood (2011) 118 (21): 3083.

https://doi.org/10.1182/blood.V118.21.3083.3083

Published: 2011

Journal Articles

Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma

Hawk Kim, Je-Hwan Lee, M.D., Young Don Joo, M.D., Sung Hwa Bae, MD, Jung-Hee Lee, M.D., Dae-Young Kim, M.D., Won-Sik Lee, MD, Hun-Mo Ryoo, MD, PhD, Jung Lim Lee, Jae Hoo Park, Kyoo Hyung Lee, M.D.

Blood (2011) 118 (21): 4952.

https://doi.org/10.1182/blood.V118.21.4952.4952

Published: 2011

Journal Articles

Improved Survival and Recovery of Hematopoiesis Following Lethal Radiation by Chloroquine-Mediated Activation of ATM

Yiting Lim, BS, Mohammad Hedayati, PhD, Akil Merchant, MD, Yonggang Zhang, MD, Theodore DeWeese, MD, William Matsui, MD

Blood (2010) 116 (21): 2228.

https://doi.org/10.1182/blood.V116.21.2228.2228

Published: 2010

Journal Articles

Gemcitabine, Busulfan and Melphalan (GemBuMel) Is a New High-Dose Chemotherapy (HDC) Regimen with High Activity In Refractory Hodgkin's Lymphoma (HL) Patients Receiving An Autologous Stem-Cell Transplant (ASCT): A Contemporaneous Comparison with BEAM and Busulfan/Melphalan (BuMel)

Yago Nieto, MD, Paolo Anderlini, MD, Uday Popat, MD, Ping Liu, MS, Borje S Andersson, MD, PhD, Elizabeth J. Shpall, MD, Partow Kebriaei, MD, Chitra Hosing, MD, Amin M Alousi, MD, Muzaffar H. Qazilbash, MD, Stefan O. Ciurea, MD, Simrit Parmar, MD, Richard E. Champlin, MD, Roy Jones, PhD, MD

Blood (2010) 116 (21): 690.

https://doi.org/10.1182/blood.V116.21.690.690

Published: 2010

Journal Articles

Safe and Efficient Chelation by Deferasirox In Thalassemia Major Patients with Low Liver and Cardiac Iron Concentrations

Regine Grosse, Gritta Janka, MD, PhD, Andrea Jarisch, PhD, MD, Peter Nielsen, Jin Yamamura, Roland Fischer, PhD

Blood (2010) 116 (21): 5168.

https://doi.org/10.1182/blood.V116.21.5168.5168

Published: 2010

Journal Articles

Bone Marrow Derived Mesenchymal Stem Cells and Radiation Response: a Kinetic Study of Gene Response Using Microarray Analysis.

Philippe Garrigou, Jean-Francois Mayol, Catherine Mouret, Christophe Delaunay, Michel Drouet, Francis Herodin, Andre Peinnequin, Pascal Pugnière

Blood (2009) 114 (22): 4575.

https://doi.org/10.1182/blood.V114.22.4575.4575

Published: 2009

Journal Articles

Correction of Murine Adamts13 Deficiency by Hematopoietic Progenitor Cell-Mediated Gene Therapy

Pablo Laje, Dezhi Shang, Masayuki Endo, Wenjing Cao, Philip W. Zoltick, Alan W. Flake, X. Long Zheng

Blood (2008) 112 (11): 2356.

https://doi.org/10.1182/blood.V112.11.2356.2356

Published: 2008

Journal Articles

Intraindividual Comparison between Deferasirox and Deferoxamine in Thalassemia.

Roland Fischer, PhD, Regine Grosse, Rainer Engelhardt, PhD, Peter Nielsen, PhD, MD, Oliver Leismann, PhD, Gritta E. Janka, MD

Blood (2007) 110 (11): 2776.

https://doi.org/10.1182/blood.V110.11.2776.2776

Published: 2007

Journal Articles

Chelator Efficacy of Deferasirox and Deferoxamine Determined by SQUID Biosusceptometry.

Regine Grosse, Gisela Janssen, Rainer Engelhardt, Marketa Groeger, Oliver Leismann, Peter Nielsen, Roland Fischer, Gritta Janka

Blood (2006) 108 (11): 1779.

https://doi.org/10.1182/blood.V108.11.1779.1779

Published: 2006

Journal Articles

HE2100 (5-Androstene-3β,17β-diol) after Cytoreductive Total Body Irradiation of Rhesus Monkeys Promotes the Recovery of Immature CD34+ Bone Marrow Cells, Accelerates Platelet, Granulocyte and Red Cell Reconstitution, and Alleviates Neutropenia and Anemia.

Fatima S.F. Kaya-Aerts, MD, Trudi P. Visser, BSc, Chris L. Reading, PhD, James M. Frincke, PhD, Monique M.A. Verstegen, PhD, Dwight R. Stickney, MD, Gerard Wagemaker, PhD

Blood (2005) 106 (11): 4203.

https://doi.org/10.1182/blood.V106.11.4203.4203

Published: 2005

Journal Articles

Secondary Malignancies after Hematopoietic Stem Cell Transplantation in Patients Treated with Total Body Irradiation.

Cristina de la Fuente, MD, Maria I. Berrocal, MD, J. Rafael Cabrera, MD, PhD, Carlos A. Regueiro, MD, PhD, Rafael Fores, MD, Carmen Regidor, MD, PhD, Isabel Millan, MD, Luis Nuñez, MD, PhD, Francisco Valcarcel, MD, PhD, Manuel N. Fernandez, MD, PhD, Isabel Sanjuan, MD, PhD, Alejandro de la Torre, MD, PhD

Blood (2005) 106 (11): 2741.

https://doi.org/10.1182/blood.V106.11.2741.2741

Published: 2005

NARROW

Enhanced and Accelerated Repopulation of Mutant C-Kit Immunodeficient Mice By Transplants of Primary Chronic and Acute Myeloid Leukemic Human Cells

Prospective Phase 2 Trial of High-Dose Gemcitabine/Busulfan/Melphalan (Gem/Bu/Mel) with Autologous Stem-Cell Transplant (ASCT) without Post-ASCT Maintenance, in Hodgkins Lymphoma Patients at High Risk of Post-Transplant Recurrence Comparison with a Concurrent Matched Cohort Treated with BEAM

Bone Marrow Iron Assessment By MRI-R2* and Its Relation to Deferasirox Treatment in Patients with Iron Overload

Longterm Multilineage Human Hematopoietic Repopulation of Untreated KIT-Mutant Immunodeficient Mice

Extreme Heterogeneity Of Myeloablative Total Body Irradiation (TBI) Techniques Across Europe: A Survey Of Acute Leukemia Working Party Of The EBMT

High-Dose Gemcitabine Combined With Busulfan and Melphalan (Gem/Bu/Mel) With Autologous Stem-Cell Transplant (ASCT) In Refractory and Relapsed Myeloma

Vorinostat (SAHA) Combined With High-Dose Gemcitabine/Busulfan/Melphalan (SAHA/Gem/Bu/Mel) With Autologous Stem-Cell Transplant (ASCT) In Patients With Refractory Lymphomas

Beneficial Effects Of Ionizing Radiation To Enhance Anti-Cancer Effects Of RIG-Like Receptor Stimulus

Would Be Cyclophosphamide, Thalidomide and Dexamethasone (CTD) a Possible Treatment For Multiple Myeloma Where Is Not Possible New Drugs?

High-Dose Infusional Gemcitabine (Gem) Combined with Busulfan (Bu) and Melphalan (Mel) (GemBuMel) with Autologous Stem-Cell Transplant (ASCT) in Patients with Refractory Lymphoid Malignancies

Biweekly Gemcitabine-Oxaliplatin and Dexamethasone for Relapsed/Refractory Malignant Lymphoma

Improved Survival and Recovery of Hematopoiesis Following Lethal Radiation by Chloroquine-Mediated Activation of ATM

Gemcitabine, Busulfan and Melphalan (GemBuMel) Is a New High-Dose Chemotherapy (HDC) Regimen with High Activity In Refractory Hodgkin's Lymphoma (HL) Patients Receiving An Autologous Stem-Cell Transplant (ASCT): A Contemporaneous Comparison with BEAM and Busulfan/Melphalan (BuMel)

Safe and Efficient Chelation by Deferasirox In Thalassemia Major Patients with Low Liver and Cardiac Iron Concentrations

Bone Marrow Derived Mesenchymal Stem Cells and Radiation Response: a Kinetic Study of Gene Response Using Microarray Analysis.

Correction of Murine Adamts13 Deficiency by Hematopoietic Progenitor Cell-Mediated Gene Therapy

Intraindividual Comparison between Deferasirox and Deferoxamine in Thalassemia.

Chelator Efficacy of Deferasirox and Deferoxamine Determined by SQUID Biosusceptometry.

HE2100 (5-Androstene-3β,17β-diol) after Cytoreductive Total Body Irradiation of Rhesus Monkeys Promotes the Recovery of Immature CD34+ Bone Marrow Cells, Accelerates Platelet, Granulocyte and Red Cell Reconstitution, and Alleviates Neutropenia and Anemia.

Secondary Malignancies after Hematopoietic Stem Cell Transplantation in Patients Treated with Total Body Irradiation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only